Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Clinical trial NCT01540071 · COMPLETED

Trial details

NCT number: NCT01540071
Sponsor: Io Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration Resistant Prostate Cancer

Start date: 2011-08-01
Primary completion: 2015-12-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.